ViGenCell Inc
308080
Company Profile
Business description
ViGenCell Inc specializes in immune cell therapy products. The companies various immune cell therapies has contributed to prolonged life expectancy and much enhanced quality of life for patients suffering from incurable diseases.
Contact
66 Gasan-ro 9-gil
9th floor, Therizen Valley Knowledge Industry Center
Seoul06591
KORT: +82 27850201
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
52
Stocks News & Analysis
stocks
US utilities stocks keep rallying as investors bet on power demand growth
Rising electricity demand from data centers supports earnings growth, but Morningstar analysts say the sector looks less attractive after a sharp rally.
stocks
What did Morningstar subscribers buy and sell during March?
How the most traded shares in March stack up against our analysts views.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,165.10 | 41.30 | -0.45% |
| CAC 40 | 8,299.73 | 63.75 | 0.77% |
| DAX 40 | 23,995.62 | 253.18 | 1.07% |
| Dow JONES (US) | 48,218.25 | 301.68 | 0.63% |
| FTSE 100 | 10,590.83 | 7.87 | 0.07% |
| HKSE | 25,872.32 | 211.47 | 0.82% |
| NASDAQ | 23,183.74 | 280.84 | 1.23% |
| Nikkei 225 | 57,877.39 | 1,374.62 | 2.43% |
| NZX 50 Index | 13,017.26 | 2.92 | -0.02% |
| S&P 500 | 6,886.24 | 69.35 | 1.02% |
| S&P/ASX 200 | 8,970.80 | 43.20 | -0.48% |
| SSE Composite Index | 4,026.63 | 38.07 | 0.95% |